AstraZeneca Discloses EU Vaccine Contract After Supply Spat

AstraZeneca Plc bowed to pressure from the European Union and published its contract for the delivery of Covid-19 vaccines to the region as tensions escalate over an expected shortfall in supplies.

The text suggests that U.K. manufacturing sites can be counted toward the company’s arrangements for the EU, which has been a subject of dispute between the bloc and the British drugmaker. But the contract says only that the company should exercise “best reasonable efforts” to resolve problems arising from competing supply agreements.